Literature DB >> 19665538

No effect of acute, single dose oral administration of Momordica charantia Linn., on glycemia, energy expenditure and appetite: a pilot study in non-diabetic overweight men.

Gursevak S Kasbia1, Jon Thor Arnason, Pascal Imbeault.   

Abstract

AIM OF THE STUDY: Momordica charantia Linn. Cucurbitaceae (MC), has been used to treat glycemic impairment in humans for centuries. The objective of this study was to determine the acute effect of MC on postprandial glucose levels, energy expenditure/fuel mixture and appetite in overweight men.
MATERIALS AND METHODS: Five healthy overweight men were supplemented on three randomized conditions where (1) no MC (placebo), (2) 50 mg/kg body weight (MC50) or (3) 100 mg/kg body weight of freeze dried MC were administered orally prior to a 75 g oral glucose tolerance test (OGTT). Plasma glucose and insulin levels were measured before and during the OGTT. Energy expenditure as well as carbohydrate and lipid oxidation rates were measured by indirect calorimetry. Visual analogue scales were used to rate appetite profile.
RESULTS: Plasma glucose and insulin levels significantly increased during the OGTT (p < or =0.05) but no significant difference was observed between experimental conditions. Energy expenditure, carbohydrate and lipid oxidation rates as well as appetite profile did not differ between experimental conditions.
CONCLUSIONS: These results suggest that from an acute standpoint, a freeze dried MC extraction in its present dose form does not affect plasma glucose/insulin levels, energy expenditure, substrate mixture and appetite scores following an oral glucose load in non-diabetic overweight men.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19665538     DOI: 10.1016/j.jep.2009.07.035

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  8 in total

1.  Traditional medicinal plants used for the treatment of diabetes in rural and urban areas of Dhaka, Bangladesh--an ethnobotanical survey.

Authors:  Soeren Ocvirk; Martin Kistler; Shusmita Khan; Shamim Hayder Talukder; Hans Hauner
Journal:  J Ethnobiol Ethnomed       Date:  2013-06-24       Impact factor: 2.733

Review 2.  Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes.

Authors:  Jimmy T Efird; Yuk Ming Choi; Stephen W Davies; Sanjay Mehra; Ethan J Anderson; Lalage A Katunga
Journal:  Int J Environ Res Public Health       Date:  2014-02-21       Impact factor: 3.390

3.  Acute effects of a beverage containing bitter melon extract (CARELA) on postprandial glycemia among prediabetic adults.

Authors:  C H Boone; J R Stout; J A Gordon; M J Redd; D D Church; L P Oliveira; D H Fukuda; J R Hoffman
Journal:  Nutr Diabetes       Date:  2017-01-16       Impact factor: 5.097

4.  Safety assessment of McB-E60 (extract of a Momordica sp.): Subchronic toxicity study in rats.

Authors:  Narendra S Deshmukh
Journal:  Toxicol Rep       Date:  2016-05-24

Review 5.  The Effect of Momordica charantia in the Treatment of Diabetes Mellitus: A Review.

Authors:  Zhuo Liu; Jing Gong; Wenya Huang; Fuer Lu; Hui Dong
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-16       Impact factor: 2.629

6.  Bitter Melon (Momordica charantia L.) Fruit Bioactives Charantin and Vicine Potential for Diabetes Prophylaxis and Treatment.

Authors:  Farhan Saeed; M Tauseef Sultan; Ayesha Riaz; Sagheer Ahmed; Nicusor Bigiu; Ryszard Amarowicz; Rosana Manea
Journal:  Plants (Basel)       Date:  2021-04-08

Review 7.  Advanced Bioinformatics Tools in the Pharmacokinetic Profiles of Natural and Synthetic Compounds with Anti-Diabetic Activity.

Authors:  Ana Maria Udrea; Gratiela Gradisteanu Pircalabioru; Anca Andreea Boboc; Catalina Mares; Andra Dinache; Maria Mernea; Speranta Avram
Journal:  Biomolecules       Date:  2021-11-14

8.  Effect of superfine grinding on antidiabetic activity of bitter melon powder.

Authors:  Ying Zhu; Ying Dong; Xiwen Qian; Fengjie Cui; Qin Guo; Xinghua Zhou; Yun Wang; Yi Zhang; Zhiyu Xiong
Journal:  Int J Mol Sci       Date:  2012-11-02       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.